← Leaderboards
Edward Perez-Reyes
University Of Virginia Charlottesville
$8,746,219
Attributed
$8,960,013
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $709K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,960,013 · 11
By mechanism
R01$5,651,898 · 4
R21$1,643,219 · 4
R61$726,750 · 1
R56$531,451 · 1
R33$406,695 · 1
Top collaborators
- Manoj K Patel2 shared
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsGrantEpilepsyPharmaceutical PreparationsGenesAffectAnimal ModelSeizuresRattusPharmacologyRodentAnimalsFundingCalcium ChannelHippocampus (Brain)Antiepileptic AgentsNovel TherapeuticsTemporal Lobe EpilepsyAmericanMedicineDoxycyclineMedicalBaseFuture
Grant awards (29)
Novel Cre-Dependent AAVs with Minimal Off-Target Expression to Study Neural Circuits$426,939
R01 · FY2025 · MH · contact PI
Novel Cre-Dependent AAVs with Minimal Off-Target Expression to Study Neural Circuits$407,589
R01 · FY2024 · MH · contact PI
Developing a drug-inducible gene therapy for temporal lobe epilepsy$531,451
R56 · FY2023 · NS · contact PI
Validation of a Novel Mouse Model of Temporal Lobe Epilepsy$406,695
R33 · FY2022 · NS · contact PI
Validation of a novel mouse model of temporal lobe epilepsy$363,375
R61 · FY2020 · NS · contact PI
Validation of a novel mouse model of temporal lobe epilepsy$363,375
R61 · FY2019 · NS · contact PI
Developing a drug-inducible gene therapy for temporal lobe epilepsy$345,625
R01 · FY2019 · NS · contact PI
Developing a drug-inducible gene therapy for temporal lobe epilepsy$345,625
R01 · FY2018 · NS · contact PI
Developing a drug-inducible gene therapy for temporal lobe epilepsy$345,625
R01 · FY2017 · NS · contact PI
Developing a drug-inducible gene therapy for temporal lobe epilepsy$345,625
R01 · FY2016 · NS · contact PI
Probing epileptic circuits with novel Cre- and drug-regulated genetic approaches$197,500
R21 · FY2016 · NS · contact PI
Probing epileptic circuits with novel Cre- and drug-regulated genetic approaches$237,000
R21 · FY2015 · NS · contact PI
Na Channel beta4 as a Gene Therapy Target for Epilepsy$190,588
R21 · FY2013 · NS · contact PI
Neuron-specific block of T-type calcium channels$246,081
R21 · FY2012 · NS · contact PI
Na Channel beta4 as a Gene Therapy Target for Epilepsy$237,000
R21 · FY2012 · NS · contact PI
Neuron-specific block of T-type calcium channels$198,460
R21 · FY2011 · NS · contact PI
Mechanisms by which T-type calcium channels increase seizure susceptibility$385,000
R01 · FY2010 · NS · contact PI
Mechanisms by which T-type calcium channels increase seizure susceptibility$385,000
R01 · FY2009 · NS · contact PI
Molecular Analysis of Neuronal T Type CA++ Channels$333,854
R01 · FY2007 · NS · contact PI
Development of High Throughput Assays for N-type Calcium Channels$165,496
R21 · FY2007 · NS · contact PI
Molecular Analysis of Neuronal T Type CA++ Channels$343,826
R01 · FY2006 · NS · contact PI
Development of High Throughput Assays for HVA CA Channels$171,094
R21 · FY2006 · NS · contact PI
Molecular Analysis of Neuronal T Type CA++ Channels$352,004
R01 · FY2005 · NS
Molecular Analysis of Neuronal T Type CA++ Channels$336,230
R01 · FY2004 · NS
MOLECULAR ANALYSIS OF NEURONAL T TYPE CA++ CHANNELS$350,197
R01 · FY2003 · NS
MOLECULAR ANALYSIS OF NEURONAL T TYPE CA++ CHANNELS$335,516
R01 · FY2002 · NS
MOLECULAR ANALYSIS OF NEURONAL T TYPE CA++ CHANNELS$321,458
R01 · FY2001 · NS
MOLECULAR ANALYSIS OF NEURONAL T TYPE CA++ CHANNELS$185,977
R01 · FY2000 · NS
MOLECULAR ANALYSIS OF NEURONAL T TYPE CA++ CHANNELS$105,808
R01 · FY2000 · NS